Intensive vs Traditional Cardiac Rehabilitation for Cardiovascular Disease
(CREDIBLE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether Intensive Cardiac Rehabilitation (ICR) surpasses Traditional Cardiac Rehabilitation (TCR) for individuals with heart disease. Researchers aim to determine if ICR can lower hospital readmission costs, reduce major heart problems, and improve health markers. Participants may also receive healthy food deliveries to assess whether this boosts the benefits of ICR. The trial seeks individuals who have recently experienced heart issues, such as a heart attack or heart surgery, and could benefit from a structured rehab program. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance cardiac care for future patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Intensive Cardiac Rehabilitation (ICR) is generally safe for people with heart conditions, regardless of specific dietary components. Studies have found that participants tolerate ICR well, with no major problems reported.
In one study, patients who participated in the ICR program, which included personalized exercise sessions, experienced improvements in heart health without serious side effects. The program incorporates safe exercise routines, healthy eating, and stress management, all of which contribute to better heart health.
The program also includes C2life® foods to support a heart-healthy diet, and no evidence suggests these foods cause harm. Overall, research indicates that joining an ICR program is a safe way to enhance heart health.12345Why are researchers excited about this trial?
Researchers are excited about these cardiac rehabilitation methods because they offer a fresh approach to improving heart health for those with cardiovascular disease. Unlike traditional cardiac rehab, which typically involves a 36-session program, the intensive cardiac rehab (ICR) approach doubles the engagement with a 72-session program. This increased frequency could potentially lead to better long-term outcomes by keeping patients more engaged and active in their recovery. Additionally, one of the ICR options includes meals provided by C2life®, which aims to support patients nutritionally throughout their rehab, potentially enhancing the overall benefits of the program. These features may provide a more comprehensive and supportive recovery experience compared to standard care.
What evidence suggests that this trial's treatments could be effective for cardiovascular disease?
This trial will compare Intensive Cardiac Rehabilitation (ICR) with Traditional Cardiac Rehabilitation (TCR). Research has shown that ICR can be more effective for heart health than TCR. Specifically, studies have found that ICR programs, such as the Ornish and Pritikin programs, greatly reduce risk factors for heart disease and improve heart health. For instance, patients in these programs experienced fewer major heart problems, like heart attacks, and showed better health improvements. In this trial, some participants will receive ICR with a nutrition component, such as C2life® food, which may further enhance these benefits. Overall, evidence suggests that ICR could lead to better heart health compared to traditional methods.13456
Who Is on the Research Team?
Brian Asbill, MD
Principal Investigator
Mission Health
David Beckner, MD
Principal Investigator
Ballad Health
Frank A. Smith, MD
Principal Investigator
Trinity Health System
James R. Hebert, ScD, MSPH
Principal Investigator
Connecting Health Innovations, LLC (CHI)
Are You a Good Fit for This Trial?
This trial is for individuals with cardiovascular disease who are eligible for cardiac rehabilitation. Participants will be randomly assigned to one of three groups: an intensive rehab program with special food delivery, the same without food, or a traditional rehab program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Rehabilitation Intervention
Participants undergo either Intensive Cardiac Rehabilitation (ICR) or Traditional Cardiac Rehabilitation (TCR) with biometric and laboratory measurements at entry and discharge.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with measurements at 6 months post-discharge.
Long-term Follow-up
Post-hoc EMR analysis for readmission rates and MACE up to 5 years.
What Are the Treatments Tested in This Trial?
Interventions
- Intensive Cardiac Rehabilitation
- Traditional Cardiac Rehabilitation
Intensive Cardiac Rehabilitation is already approved in United States, European Union, Canada for the following indications:
- Acute myocardial infarction
- Coronary bypass surgery
- Stable angina pectoris
- Heart valve repair or replacement
- Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting
- Heart or heart-lung transplant
- Myocardial infarction
- Coronary artery bypass grafting
- Stable angina
- Heart failure
- Valvular surgery
- Cardiac transplantation
- Recent myocardial infarction
- Acute coronary artery syndrome
- Chronic stable angina
- Congestive heart failure
- After coronary artery bypass surgery
- After a percutaneous coronary intervention
- Valvular surgery
- Cardiac transplantation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Pritikin ICR
Lead Sponsor
Ballad Health
Collaborator
Mission Health System, Asheville, NC
Collaborator
Trinity Health
Collaborator
Connecting Health Innovation
Collaborator
Trinity Health System
Industry Sponsor